IBM
60
6
CRM
65
6
K
57
4
AFL
49
3
STZ
57
2
GT
56
2
PDCO
38
3
KEY
43
3
ZTS
49
2
OKE
81
3
CNP
63
3
MLM
51
3
OMC
61
6
BIIB
28
2
CI
52
7
RHI
57
3
ETN
79
4
GOOG
53
-12
FDX
40
4
BWA
46
2
IBM
60
6
CRM
65
6
K
57
4
AFL
49
3
STZ
57
2
GT
56
2
PDCO
38
3
KEY
43
3
ZTS
49
2
OKE
81
3
CNP
63
3
MLM
51
3
OMC
61
6
BIIB
28
2
CI
52
7
RHI
57
3
ETN
79
4
GOOG
53
-12
FDX
40
4
BWA
46
2
Financhill
Back

Mereo BioPharma Group PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
45

MREO
Mereo BioPharma Group PLC

Last Price:
3.73
Seasonality Move:
12.89%
Sell
20

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.66
Seasonality Move:
50.57%
Sell
45
Mereo BioPharma Group PLC (MREO) is a Sell

Is Mereo BioPharma Group PLC a Buy, Sell or Hold?

  • The current Mereo BioPharma Group PLC [MREO] share price is $3.68. The Score for MREO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • MREO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.64. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MREO Stock Price Chart

What is Mereo BioPharma Group PLC's stock price today?

  • The Mereo BioPharma Group PLC share price today is $3.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MREO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.

MREO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 39.84 Sell
Chaikin Money Flow: 678381 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.76 - 4.4) Sell
Bollinger Bands (100): (3.83 - 4.47) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 36.24 Sell
Chaikin Money Flow: -608296 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.82) Sell
Bollinger Bands (100): (0.81 - 1.21) Sell

MREO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.7 Sell
20-day SMA: 3.99 Sell
50-day SMA: 4.16 Sell
200-day SMA: 3.74 Sell
8-day EMA: 3.7 Sell
20-day EMA: 3.92 Sell
50-day EMA: 4.08 Sell
200-day EMA: 3.66 Buy

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.66 Sell
20-day SMA: 0.73 Sell
50-day SMA: 0.85 Sell
200-day SMA: 1.12 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.73 Sell
50-day EMA: 0.83 Sell
200-day EMA: 1 Sell

Mereo BioPharma Group PLC Earnings Growth & MREO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.00 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

Mereo BioPharma Group PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):